For instance, little is known regarding how specific oncogenic mutations, such as those of the phosphatidylinositol 3 kinase (PI3K) pathway that frequently occur in human breast cancer, influence how a cell interacts with the fundamental ECM architectures of the tumor microenvironment (TME). Here, PIK3CA is linked to breast cancer.